Last $29.51 USD
Change Today -0.05 / -0.17%
Volume 232.5K
ACOR On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 5:20 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jane Wasman J.D.

General Counsel, Corporate Secretary and President of International, Acorda Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 1 different industries.

See Board Relationships
58$2,159,622
As of Fiscal Year 2013

Background*

Ms. Jane Wasman, J.D., has been General Counsel and Corporate Secretary of Acorda Therapeutics since July 2004 and its President of International since October 09, 2012. Ms. Wasman served as the Chief of Strategic Development of Acorda Therapeutics, Inc. since February 2012. She has also been Executive Vice President of Acorda Therapeutics since July 2004. She served as Staff Vice President and Associate General Counsel at Schering-Plough Corporation, supporting U.S. ...

Read Full Background

Corporate Headquarters*

420 Saw Mill River Road
Ardsley, New York 10502

United States

Phone: 914-347-4300
Fax: 914-347-4560

Board Members Memberships*

Member of the Board of Directors

Education*

Bachelor's Degree
Princeton University
JD
Harvard Law School

Other Affiliations*

Annual Compensation*

Salary$515,167
Bonus$2,500
Total Annual Compensation$517,667

Stock Options*

Restricted Stock Awards$342,919
All Other Compensation$7,650
Exercisable Options343,113
Unexercisable Options138,774
Total Number of Options481,887

Total Compensation*

Total Annual Cash Compensation$827,842
Total Short Term Compensation$517,667
Other Long Term Compensation$350,569
Total Calculated Compensation$2,159,622
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACOR:US $29.51 USD -0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACORDA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.